PETVW 最新10-K变化

相对上期新增的文字 · 来源:10-K · 2026-06-29

• As of March 31, 2026, we have cash or cash equivalents of approximately $201,000. We anticipate that we will be adequate to satisfy operational and capital requirements for the next one (1) month. Also, an investor shareholder has a Purchase Option to invest up to $1.5 million into the company by Ju…

• If we are unable to realize substantial revenues in the near future, we will need to seek additional financing beyond this three-month period to continue our operations. We also most likely will require additional financing to develop additional new products or to expand into foreign markets. Accord…

相对上期删除的文字 · 来源:10-K · 2025-07-10

• As of March 31, 2025, we have cash or cash equivalents of approximately $228,000. We anticipate that we will be adequate to satisfy operational and capital requirements for the next one (1) month. If we are unable to realize substantial revenues in the near future, we will need to seek additional fi…

相对上期新增的文字 · 来源:10-K · 2026-06-29

• Other Income (Expense). Other expense was ($1,410,710) in fiscal 2026 compared to other expense of ($343,446) in fiscal 2025. Other expense in fiscal 2026 consisted of interest expense of ($1,065,797), loss on asset disposal of ($149,125), unrealized loss on change in derivative liability of ($320,4…

• As of March 31, 2026, our current assets were $1,859,921 including $200,782 in cash and cash equivalents. In comparison, our current liabilities as of that date were $1,377,292 including $1,001,134 of accounts payable and accrued expenses. Our working capital as of March 31, 2026 was $482,629.

• conditions. There can be no guarantee that the Company will be successful in its ability to raise additional capital to fund its business plan.

• Net Cash Used in Operating Activities – We used $6,107,286 of net cash in operating activities in fiscal 2026. This cash used in operating activities was primarily attributable to our net loss of $10,349,084, offset by stock based compensation of $1,879,890, loss on impairment of licensing agreement…

• Net Cash Provided in Investing Activities – During fiscal 2026, we were provided $11,800 of net cash in due to the return of a security deposit received from a lease termination offset by the purchase of property and equipment.

相对上期删除的文字 · 来源:10-K · 2025-07-10

• Other Income (Expense). Other expense was ($343,446) in fiscal 2025 compared to other expense of ($333,955) in fiscal 2024. Other expense in fiscal 2025 consisted of extinguishment of payables of $66,076, sublease rental income of $42,000, an IRS payroll tax refund from a prior year of $16,800, inte…

• On March 26, 2025, the Company entered into a Subscription Agreement for $5,000,000 in a Series B Preferred Offering, whereby $600,000 was received, with the remaining $4,400,000 proceeds received in May and June 2025. As of March 31, 2025, our current assets were $1,041,660 including $87,403 in cas…

• Net Cash Used in Operating Activities – We used $4,521,930 of net cash in operating activities in fiscal 2025. This cash used in operating activities was primarily attributable to our net loss of $8,399,166, offset by stock based compensation of $1,107,520, and an increase in accounts payable and ac…

• Net Cash Used in Investing Activities – We used 1,063,436 of net cash in investing activities in fiscal 2025 due to the purchase of the VetStem Licensing Agreement and the purchase of equipment.

• Net Cash Provided by Financing Activities – During fiscal 2025, we were provided with net cash of 5,725,652 from financing activities consisting primarily of $1,818,000 from the proceeds of the sale of preferred stock, $2,050,100 from the proceeds of the sale of common stock and warrants, and $1,565…